← Open Payments lookup

MARK FRAZEE: Open Payments

NPI 1295999001 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$337 in 12 payments from 11 companies in 2025. Trend: 2023 $178 · 2024 $200 · 2025 $337

Food & beverage: $337
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$124
Actelion Pharmaceuticals US, Inc.2$32
Verona Pharma, Inc.1$30
GENZYME CORPORATION1$26
Viatris Specialty LLC1$26
Bayer Healthcare Pharmaceuticals Inc.1$19
Electromed, Inc.1$18
Takeda Pharmaceuticals U.S.A., Inc.1$17
AstraZeneca Pharmaceuticals LP1$16
PFIZER INC.1$15

Products named: XIFAXAN, OPSUMIT, Ohtuvayre, DUPIXENT, YUPELRI, Adempas, SMARTVEST, GLASSIA.

Industry payments across IN — which companies pay providers there.